Literature DB >> 7262515

The pH gradient across mucus adherent to rat fundic mucosa in vivo and the effect of potential damaging agents.

I N Ross, H M Bahari, L A Turnberg.   

Abstract

We investigated the possibility that a "mucus-bicarbonate" barrier might exist in the stomach in vivo. Using an antimony microelectrode a pH gradient was demonstrated across the mucus layer on the fundic mucosa of the rat stomach in vivo. When the luminal pH was 2.0 the maximum pH reached on traversing the mucus layer was 6.68 +/- 0.71 (n = 30) and a stable gradient could be maintained across the mucus for over 100 min. Introduction of luminal solutions with a pH of less than 1.5 caused a fall in the pH gradient and its abolition at pH 1.2. N-Acetyl-L-cysteine (5%) in pH 2.0 luminal HCl solution caused a fall in pH in 12 of 18 rats within 5 min. After 30 to 60 min exposure the maximum mean pH in 12 rats was reduced to 4.18 +/- 0.92 (p less than 0.001). Ten millimolar aspirin in pH 2.0 HCl also caused a fall in pH in 12 of 24 rats within 10 min and the maximum pH in 12 rats after 30-60 min exposure was 4.13 +/- 0.84 (p less than 0.001). These effects on the mucus pH gradient were local actions because in other, untreated areas of the same stomachs there was a normal maximum pH. Ten millimolar sodium taurocholate in pH 2.0 HCl produced a visible clouding of the mucus layer, but no fall in pH. However, gentle manipulation caused the mucus to "flake" off with a subsequent fall in underlying pH. These observations indicate the presence of a pH gradient in mucus in vivo which can be compromised by agents which interfere with mucus structure and/or bicarbonate secretion and by high intraluminal hydrogen ion concentrations. The results support a role for this barrier in gastric mucosal protection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7262515

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  26 in total

Review 1.  Mechanisms of NSAID-induced gastroenteropathy.

Authors:  A H Price; M Fletcher
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Gastroduodenal mucosal surface and luminal pH in gastric ulcer.

Authors:  J W Rawlings; B J Danesh; M L Lucas; R J Morgan; A N Main; R I Russell
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

3.  Brain ischemia and gastric mucosal damage in spontaneously hypertensive rats: the role of arterial vagal adrenoceptors.

Authors:  K Kawakubo; S Ibayashi; T Nagao; K Doi; K Aoyagi; M Iida; S Sadoshima; M Fujishima
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

4.  Peptic ulcer disease. Pathophysiology and current medical management.

Authors:  B F Scharschmidt
Journal:  West J Med       Date:  1987-06

5.  Endogenous cyclo-oxygenase activity regulates mouse gastric surface pH.

Authors:  Heidi K Baumgartner; Uzay Kirbiyik; Tamer Coskun; Shaoyou Chu; Marshall H Montrose
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

6.  Mucosal surface pH of the large intestine of the rat and of normal and inflamed large intestine in man.

Authors:  N I McNeil; K L Ling; J Wager
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

7.  Effects of non-steroidal anti-inflammatory drugs and prostaglandins on alkali secretion by rabbit gastric fundus in vitro.

Authors:  W D Rees; L C Gibbons; L A Turnberg
Journal:  Gut       Date:  1983-09       Impact factor: 23.059

8.  Fluoride absorption: the influence of gastric acidity.

Authors:  G M Whitford; D H Pashley
Journal:  Calcif Tissue Int       Date:  1984-05       Impact factor: 4.333

9.  A new method for measurement of blood flow, pH, and transmucosal potential difference in rat gastroduodenal mucosa by endoscopy.

Authors:  M Uchida; N Misaki; O Kawano
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

10.  Effect of luminal pH on the output of bicarbonate and PGE2 by the normal human stomach.

Authors:  J R Crampton; L C Gibbons; W D Rees
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.